Tech Tonics: Linda Avey, We Are Curious

Image for FaceBook

Share this post:
Facebook | Twitter | Google+ | LinkedIn | Pinterest | Reddit | Email
This post can be linked to directly with the following short URL:

The audio player code can be copied in different sizes:
144p, 240p, 360p, 480p, 540p, Other

The audio player code can be used without the image as follows:

This audio file can be linked to by copying the following URL:

Right/Ctrl-click to download the audio file.
Connected Social Media - iTunes | Spotify | Google | Stitcher | TuneIn | Twitter | RSS Feed | Email
Tech Tonics - iTunes | Spotify | Google | Stitcher | TuneIn | Twitter | RSS Feed | Email

When 23andMe veteran Linda Avey pitched her new startup, We Are Curious (which focuses on integrating patient-reported symptoms and experiences) she thought she’d emphasize a condition that seemed like an easy win: menopause-associated symptoms.

VCs, she reasoned, would be immediately grasp the size and associated economics of this market, the need to better understand the experience of these patients. Avey was wrong. The response to her presentation was generally crickets. (Presumably, this was a condition unfamiliar to VCs – and yet to be experienced by their second wives.)

Ultimately, after adjusting her presentation to focus on other conditions, Avey received strong investor support – but the initial reaction has stuck with her.

On the latest episode of Tech Tonics, Avey shares her experiences as a cutting-edge entrepreneur, dealing with challenges from regulators (like the FDA) and investors (like VCs not familiar with menopause), while creating new companies that challenge and reinvent healthcare’s status quo, and usher in a new era of participant-focused science and medicine.

We are delighted to welcome Linda Avey to our podcast!

Tags: , , , , , , , , , , , , , , , , , , , , , , , , ,
Posted in: Audio Podcast, Healthcare, Tech Tonics